132 related articles for article (PubMed ID: 7458521)
41. Kayser-Fleischer-like rings in patients with hepatic disease.
Chhikara C; Pai HV; Pai CG
Indian J Ophthalmol; 2021 May; 69(5):1084-1087. PubMed ID: 33913837
[TBL] [Abstract][Full Text] [Related]
42. Optical coherence tomography of the Kayser-Fleischer ring: an ancillary diagnostic tool for Wilson's disease in children.
Rathi A; Takkar B; Gaur N; Maharana PK
BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28476917
[TBL] [Abstract][Full Text] [Related]
43. Serum selenium concentration in patients with Wilson's disease.
Swiatkowska-Stodulska R; Dejneka W; Jabłońska-Kaszewska I; Lukasiak J; Kiszkis H; Wiśniewski P; Lubińska M; Sworczak K
Hepatogastroenterology; 2007 Sep; 54(78):1788-90. PubMed ID: 18019719
[TBL] [Abstract][Full Text] [Related]
44. Split liver transplantation for acute Wilson's disease: new option for urgent recipient?
Andorno E; Miggino M; Panaro F; Morelli N; Bottino G; Casaccia M; Jarzembowski TM; Valente U
Hepatogastroenterology; 2007; 54(77):1567-9. PubMed ID: 17708301
[TBL] [Abstract][Full Text] [Related]
45. Recent clinical features of Wilson's disease with hepatic presentation.
Kumagi T; Horiike N; Michitaka K; Hasebe A; Kawai K; Tokumoto Y; Nakanishi S; Furukawa S; Hiasa Y; Matsui H; Kurose K; Matsuura B; Onji M
J Gastroenterol; 2004 Dec; 39(12):1165-9. PubMed ID: 15622480
[TBL] [Abstract][Full Text] [Related]
46. [Occurrence of copper metabolism abnormalities in the families of four individuals with newly diagnosed Wilson's disease].
Dastych M
Vnitr Lek; 1997 Feb; 43(2):87-90. PubMed ID: 9245074
[TBL] [Abstract][Full Text] [Related]
47. [Corneal disorders in Wilson's disease].
Sohajda Z; Hódos M; Módis L
Orv Hetil; 2019 Apr; 160(14):555-557. PubMed ID: 30931597
[TBL] [Abstract][Full Text] [Related]
48. [Wilson's disease in personal material--disturbances in hemostasis].
Jabłońska-Kaszewska I; Dabrowska E; Oziebłowski A
Pol Tyg Lek; 1995 Sep; 50(36-39):79-81. PubMed ID: 8650042
[TBL] [Abstract][Full Text] [Related]
49. Intrahepatocellular localization of copper in Wilson's disease.
Yano M; Sakamoto N; Takikawa T; Hayashi H
Nagoya J Med Sci; 1993 Mar; 55(1-4):131-7. PubMed ID: 8247102
[TBL] [Abstract][Full Text] [Related]
50. Significance of copper determination in late onset of Wilson's disease.
Lech T; Hydzik P; Kosowski B
Clin Toxicol (Phila); 2007 Sep; 45(6):688-94. PubMed ID: 17849244
[TBL] [Abstract][Full Text] [Related]
51. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
Prasad R; Kaur G; Walia BN
Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
[TBL] [Abstract][Full Text] [Related]
52. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
[TBL] [Abstract][Full Text] [Related]
53. Cholelithiasis in a child--an unusual presentation of Wilson's disease.
Goswami RP; Banerjee D; Shah D
J Assoc Physicians India; 2001 Nov; 49():1118-9. PubMed ID: 11868871
[TBL] [Abstract][Full Text] [Related]
54. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
[TBL] [Abstract][Full Text] [Related]
55. Factor VII deficiency and a copper metabolism disorder in a patient with Klippel-Trenaunay syndrome.
Mueller NJ; Schiller P; Shimizu N; Flury R; Aschwanden M; Widmer U; Enzler T
Dermatology; 2002; 204(3):244-7. PubMed ID: 12037456
[TBL] [Abstract][Full Text] [Related]
56. Wilson's disease: a new gene and an animal model for an old disease.
Cuthbert JA
J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
[TBL] [Abstract][Full Text] [Related]
57. Pigmented corneal rings in neonates with liver disease.
Dunn LL; Annable WL; Kliegman RM
J Pediatr; 1987 May; 110(5):771-6. PubMed ID: 3572632
[TBL] [Abstract][Full Text] [Related]
58. New knowledge of genetic pathogenesis of hemochromatosis and Wilson's disease.
Bacon BR; Schilsky ML
Adv Intern Med; 1999; 44():91-116. PubMed ID: 9929706
[TBL] [Abstract][Full Text] [Related]
59. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
[TBL] [Abstract][Full Text] [Related]
60. Kayser-Fleischer ring: hepatolenticular degeneration (Wilson's disease).
Finelli PF
Neurology; 1995 Jul; 45(7):1261-2. PubMed ID: 7617179
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
